The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
Alignment Healthcare Inc (NASDAQ: ALHC) closed the day trading at $6.78 down -1.31% from the previous closing price of $6.87. In other words, the price has decreased by -$1.31 from its previous closing price. On the day, 1.6 million shares were traded. ALHC stock price reached its highest trading level at $7.35 during the session, while it also had its lowest trading level at $6.7.
Ratios:
For a better understanding of ALHC, let’s look at its different ratios. In the meantime, Its Debt-to-Equity ratio is 1.30 whereas as Long-Term Debt/Eq ratio is at 1.30.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Piper Sandler on May-09-24, Upgraded its rating to Overweight and sets its target price to $8 from $6 previously.
On March 06, 2024, Barclays started tracking the stock assigning a Underweight rating and target price of $4.50.
Piper Sandler Downgraded its Overweight to Neutral on March 06, 2024, whereas the target price for the stock was revised from $12 to $6.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 28 ’24 when Maroney Dawn Christine sold 10,151 shares for $4.84 per share. The transaction valued at 49,131 led to the insider holds 1,976,097 shares of the business.
Kardes Hakan sold 4,363 shares of ALHC for $21,117 on Mar 28 ’24. The Chief Experience Officer now owns 430,444 shares after completing the transaction at $4.84 per share. On Mar 28 ’24, another insider, Freeman Robert Thomas, who serves as the Chief Financial Officer of the company, sold 4,299 shares for $4.84 each. As a result, the insider received 20,807 and left with 865,407 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALHC now has a Market Capitalization of 1296322432 and an Enterprise Value of 1183377024. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.64 while its Price-to-Book (P/B) ratio in mrq is 9.90. Its current Enterprise Value per Revenue stands at 0.588 whereas that against EBITDA is -10.583.
Stock Price History:
The Beta on a monthly basis for ALHC is 1.31, which has changed by -0.018571436 over the last 52 weeks, in comparison to a change of 0.2537824 over the same period for the S&P500. Over the past 52 weeks, ALHC has reached a high of $9.20, while it has fallen to a 52-week low of $4.46. The 50-Day Moving Average of the stock is 31.12%, while the 200-Day Moving Average is calculated to be 4.95%.
Shares Statistics:
Over the past 3-months, ALHC traded about 1.01M shares per day on average, while over the past 10 days, ALHC traded about 1193560 shares per day. A total of 188.95M shares are outstanding, with a floating share count of 90.98M. Insiders hold about 52.41% of the company’s shares, while institutions hold 40.81% stake in the company. Shares short for ALHC as of 1713139200 were 4690887 with a Short Ratio of 4.63, compared to 1710460800 on 4780744. Therefore, it implies a Short% of Shares Outstanding of 4690887 and a Short% of Float of 3.85.
Earnings Estimates
The current market rating for Alignment Healthcare Inc (ALHC) reflects the collective analysis of 11.0 analysts closely monitoring its performance.On average, analysts expect EPS of -$0.13 for the current quarter, with a high estimate of -$0.08 and a low estimate of -$0.16, while EPS last year was -$0.15. The consensus estimate for the next quarter is -$0.1, with high estimates of -$0.02 and low estimates of -$0.14.
Analysts are recommending an EPS of between -$0.3 and -$0.74 for the fiscal current year, implying an average EPS of -$0.64. EPS for the following year is -$0.53, with 11.0 analysts recommending between -$0.21 and -$0.71.
Revenue Estimates
10 analysts predict $625.23M in revenue for the current quarter. It ranges from a high estimate of $644.01M to a low estimate of $598M. As of the current estimate, Alignment Healthcare Inc’s year-ago sales were $439.03MFor the next quarter, 10 analysts are estimating revenue of $619.33M. There is a high estimate of $635.26M for the next quarter, whereas the lowest estimate is $591.8M.
A total of 11 analysts have provided revenue estimates for ALHC’s current fiscal year. The highest revenue estimate was $2.55B, while the lowest revenue estimate was $2.4B, resulting in an average revenue estimate of $2.5B. In the same quarter a year ago, actual revenue was $1.82BBased on 11 analysts’ estimates, the company’s revenue will be $3.07B in the next fiscal year. The high estimate is $3.37B and the low estimate is $2.9B.
